Scientists identify mechanism causing deadly blood clots after some COVID-19 vaccines

Cleveland Clinic is undertaking a Phase I clinical trial targeting triple-negative breast cancer. Credit: Tatiana from Pixabay. Anixa Biosciences has expanded its partnership with US

For the first time since Brex­it, the UK’s med­i­cines reg­u­la­tor has made use of its new ap­proval path­way that can speed drug ap­provals based on